Minocycline
규격
10118-90-8CAS 번호
(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamideIUPAC 명칭
C23H27N3O7화학식
457.5 g/mol분자량
minocycline; 10118-90-8; Minocyclin; Minociclina; Minomycin; Dynacin; Minocin; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE; Minocyn; 7-Dimethylamino-6-demethyl-6-deoxytetracycline; CL 59806; DTXSID1045033; FYY3R43WGO; Tri-minocycline; (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Minocyclinum; CHEBI:50694; NSC 141993; Minocyclinum [INN-Latin]; NCGC00183044-01; Borymycin; Minociclina [INN-Spanish]; MIY; MINO; minociclinum; Minocline; Minoz; Mino-Tabs; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-; HSDB 3130; NSC-141993; Minocin (Hydrochloride); Vectrin (Hydrochloride); UNII-FYY3R43WGO; Minocycline (USAN/INN); BRN 3077644; Lactoferrin B & Minocycline; Lactoferrin H & Minocycline; Minocycline [USAN:INN:BAN]; Minomycin;; SR-05000001675; (minocycline); Minoderm;; Aknemin;; Arestin;; Dynacin;; Minocin;; Sebomin;; Solodyn;; Akamin;; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2- CARBOXAMIDE; (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; NSC141993; Spectrum_000967; MINOCYCLINE [MI]; Prestwick0_000315; Prestwick1_000315; Prestwick2_000315; Spectrum2_001047; Spectrum3_000508; Spectrum4_000062; Spectrum5_001293; MINOCYCLINE [INN]; MINOCYCLINE [HSDB]; MINOCYCLINE [USAN]; MINOCYCLINE [VANDF]; SCHEMBL4042; CHEMBL1434; MINOCYCLINE [MART.]; SCHEMBL24315; BSPBio_002035; KBioGR_000583; KBioSS_001447; MINOCYCLINE [WHO-DD]; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-; DivK1c_000450; SPBio_000974; SPBio_002529; orb1989822; DTXCID9025033; SCHEMBL16681149; SCHEMBL29369923; SCHEMBL29416350; BCBcMAP01_000027; GTPL10831; KBio1_000450; KBio2_001447; KBio2_004015; KBio2_006583; KBio3_001535; NINDS_000450; HMS2090D03; KUC106429N; (4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide;(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide; 2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S-(4.ALPHA.,4A.ALPHA.,5A.ALPHA.,12A.ALPHA.))-; KSC-12-231B; Tox21_113643; BDBM50103599; EBC-27149; HY-17412A; LMPK07000002; AKOS015969674; CL59806; DB01017; Minocycline; Tigecycline EP Impurity C; IDI1_000450; SMP1_000191; NCGC00178854-01; NCGC00178854-02; NCGC00188954-01; NCGC00482890-01; AC-30184; CL-59806; DA-65471; SBI-0051449.P003; CAS-10118-90-8; CS-0009521; NS00007904; TIGECYCLINE IMPURITY C [EP IMPURITY]; C07225; D05045; D78303; AB00053501-03; AB00053501_04; AB00053501_05; EN300-7481098; Q415336; T131626; SR-05000001675-3; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-동의어
Minocycline 함유 제품
Minocycline 판매 기업
CT
Công ty cổ phần dược phẩm WealpharViet NamSP
STARWAY PHARM Co., Ltd.ChinaCT
Công ty TNHH dược phẩm Huy VănViet NamCT
Công ty cổ phần dược mỹ phẩm Bảo AnViet NamCT
Công ty cổ phần dược phẩm Phúc LongViet NamCT
Công ty TNHH Dược phẩm LamdaViet Nam